De Fazio Andrea, Mazzella Giovan Giuseppe, Miele Guglielmo, Bocchi Maria Beatrice, El Ezzo Omar, Capece Giacomo, Maccauro Giulio, Vitiello Raffaele
Department of Orthopaedics, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
Orthopedics and Traumatology, Catholic University of the Sacred Heart, 00168 Rome, Italy.
J Clin Med. 2025 Sep 6;14(17):6297. doi: 10.3390/jcm14176297.
: The elbow is a rare site for bone tumors, and for this reason, the literature provides little data on the epidemiology of metastatic lesions involving the distal humerus, proximal ulna, and radius. Before performing surgery of the metastatic bone, it is first necessary to consider both patients' and metastatic lesions' features in order to better choose the best possible treatment. This systematic review aims to collect data on elbow metastases, delineate primary tumors leading to such metastases, guide surgical treatment decisions, and evaluate reconstructive techniques and associated complications. : A systematic literature review was conducted in April 2024, searching the PubMed, MEDLINE, and Cochrane Library databases using specific search terms related to elbow metastases. The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) was followed. Eligible studies reported at least one patient with metastatic bone disease involving the elbow region and specified the undertaken treatment. For studies reporting multiple skeletal sites, only elbow-specific data were extracted. We excluded recurrences of primary elbow tumors. The methodological quality of included studies was assessed with the modified Coleman Methodology Score (mCMS). : In total, 28 articles (103 patients) were included. The studies were predominantly case reports (68%), with a mean mCMS of 31. Gender was reported for only 41 patients: 71% were male and 29% female. The mean age at diagnosis of elbow metastatic lesion was 55 years old. Renal cell carcinoma was the most common primary tumor (28%), followed by breast (9%) and lung cancer (6%). The distal humerus was the most frequently affected site (85%). A surgical approach was adopted in 90% of cases, whereas 10% of patients were managed conservatively. Forty-five patients underwent wide tumor resection followed by reconstructive surgery while forty-eight patients received a surgical treatment for either pathological fractures or impending fractures. : When treating elbow metastasis, a thorough evaluation of the patient is crucial, considering the patient's functional status, pain management needs, and overall prognosis; all these features influence the treatment of choice. The selected treatment should aim to provide optimal functional outcomes and minimize complications. For patients with pathological or impending fractures, single or double plate fixation is typically the preferred approach. For patients with severe, symptomatic lesions unresponsive to conservative therapy, resection followed by the implantation of a modular prosthesis usually offers the best clinical and functional outcomes.
肘部是骨肿瘤的罕见发病部位,因此,文献中关于累及肱骨远端、尺骨近端和桡骨的转移性病变的流行病学数据很少。在进行转移性骨手术之前,首先有必要考虑患者和转移性病变的特征,以便更好地选择最佳治疗方案。本系统评价旨在收集肘部转移瘤的数据,明确导致此类转移的原发肿瘤,指导手术治疗决策,并评估重建技术及相关并发症。
2024年4月进行了一项系统的文献综述,使用与肘部转移相关的特定检索词检索了PubMed、MEDLINE和Cochrane图书馆数据库。遵循系统评价和Meta分析的首选报告项目(PRISMA)。符合条件的研究报告了至少一名患有累及肘部区域的转移性骨病患者,并明确了所采取的治疗方法。对于报告多个骨骼部位的研究,仅提取肘部特定数据。我们排除了原发性肘部肿瘤的复发情况。采用改良的科尔曼方法评分(mCMS)评估纳入研究的方法学质量。
总共纳入了28篇文章(103例患者)。这些研究主要是病例报告(68%),mCMS平均为31。仅41例患者报告了性别:71%为男性,29%为女性。肘部转移性病变的平均诊断年龄为55岁。肾细胞癌是最常见的原发肿瘤(28%),其次是乳腺癌(9%)和肺癌(6%)。肱骨远端是最常受累的部位(85%)。90%的病例采用了手术方法,而10%的患者采用保守治疗。45例患者接受了广泛的肿瘤切除,随后进行重建手术,48例患者因病理性骨折或即将发生的骨折接受了手术治疗。
在治疗肘部转移瘤时,全面评估患者至关重要,要考虑患者的功能状态、疼痛管理需求和总体预后;所有这些特征都会影响治疗选择。所选治疗应旨在提供最佳的功能结果并将并发症降至最低。对于病理性或即将发生骨折的患者,单钢板或双钢板固定通常是首选方法。对于对保守治疗无反应的严重、有症状的病变患者,切除后植入模块化假体通常能提供最佳的临床和功能结果。